Clinical Trial: A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07026123) titled 'A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China' on June 10.

Brief Summary: This study is designed to evaluate the real world efficacy and safety of the liposomal irinotecan (Onivyde(R))-based treatment scheme in Chinese patients with locally advanced or metastatic pancreatic cancer, and to compare the efficacy with that of the whole pancreatic cancer population who did not receive relevant treatment.

Study Start Date: July 01

Study Type: OBSERVATIONAL

Condition: Advanced Pancreatic Cancer

Intervention: DRUG: Nal-IRI (Onivyde(R))-based t...